4//SEC Filing
Sabag Mark 4
Accession 0000950170-25-069132
CIK 0000818686other
Filed
May 11, 8:00 PM ET
Accepted
May 12, 4:00 PM ET
Size
5.3 KB
Accession
0000950170-25-069132
Insider Transaction Report
Form 4
Sabag Mark
See "Remarks"
Transactions
- Sale
Ordinary Shares
2025-05-08$18.04/sh−337,915$6,097,304→ 150,996 total
Footnotes (2)
- [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.865 to $18.265, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
Documents
Issuer
TEVA PHARMACEUTICAL INDUSTRIES LTD
CIK 0000818686
Entity typeother
Related Parties
1- filerCIK 0001721442
Filing Metadata
- Form type
- 4
- Filed
- May 11, 8:00 PM ET
- Accepted
- May 12, 4:00 PM ET
- Size
- 5.3 KB